This website uses cookies
Read our Privacy policy and Terms of use for more information.
Subscribe to our newsletter
Plus: Korean pharma's push into Latin America, and whether whole brain emulation is real science
Plus: Ratio raises $70M to scale radiopharma manufacturing, and Obsidian closes the Galera merger with $350M behind it
Plus: an FDA warning letter over informed consent, and Nona's antibody platform heads to Vienna
20 July 2026
13 July 2026
6 July 2026
29 June 2026
22 June 2026
